20.01.2015 Views

view Unit 19: Postpartum and Postabortion Family Planning

view Unit 19: Postpartum and Postabortion Family Planning

view Unit 19: Postpartum and Postabortion Family Planning

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>19</strong>.7 <strong>Postpartum</strong> Contraception Options for Women Living<br />

with HIV/AIDS<br />

• In general, women living with HIV/AIDS can use any hormonal method—COCs, POPs,<br />

progestin-only injectables, contraceptive implants—with some restrictions for women on<br />

ARV therapy. (See table below.)<br />

• LAM: If replacement feeding is acceptable, feasible, affordable, sustainable, <strong>and</strong> safe<br />

(AFASS), women living with HIV should avoid breastfeeding <strong>and</strong> not rely on LAM. But if<br />

replacement feeding does not meet these conditions, a woman living with HIV should<br />

breastfeed exclusively for the first 6 months, thereby using LAM (until her menses<br />

resumes).<br />

• FAM: Women who are infected with HIV, have AIDS, or are on ARV therapy can safely use<br />

fertility awareness methods after 3 menstrual cycles or normal secretions have returned.<br />

• Condoms: All clients, including clients living with HIV, should be counselled on condom use<br />

for dual protection <strong>and</strong> to prevent transmission of HIV to partners.<br />

The WHO MEC classifications for hormonal methods <strong>and</strong> copper-bearing IUCDs for women at<br />

high risk for or living with HIV are listed in Table <strong>19</strong>.2.<br />

Table <strong>19</strong>.2: MEC Classifications for Women Living with or at High Risk of HIV<br />

HIV Status/Condition MEC Categories for<br />

Hormonal Methods<br />

MEC Categories for<br />

Copper-Bearing IUCD<br />

High risk of HIV: Category 1 Category 2<br />

HIV infected Category 1 Category 2<br />

Has AIDS Category 1 Category 3 for insertion, Category 2 for<br />

continued use<br />

Clinically well on<br />

antiretroviral therapy<br />

Not clinically well on<br />

antiretroviral therapy<br />

Category 2*<br />

Category 2*<br />

Category 2 for insertion <strong>and</strong> continued use<br />

Category 3 for insertion, Category 2 for<br />

continued use<br />

* The exception to this is if the woman is using Ritonavir-boosted protease inhibitors. In<br />

these cases, use of COCs <strong>and</strong> POPs is contraindicated (MEC category 3). Use of implants for<br />

these women is Category 2 <strong>and</strong> use of DMPA is Category 1.<br />

<strong>19</strong>.8 Defining <strong>Postabortion</strong> <strong>Family</strong> <strong>Planning</strong><br />

<strong>Postabortion</strong> family planning is the initiation <strong>and</strong> use of family planning methods at the time of<br />

treatment for an abortion, or before fertility returns after an abortion (within 11-14 days after<br />

the abortion occurred).<br />

Importance of postabortion family planning<br />

Women who have just experienced abortion or who have just been treated for postabortion<br />

complications need immediate <strong>and</strong> easy access to family planning services. Ideally, these<br />

services should be integrated with postabortion care <strong>and</strong> offered immediately postabortion,<br />

increasing the likelihood that these women use contraception to avoid unintended pregnancy.<br />

(WHO/RHR <strong>and</strong> CCP, INFO Project 2007).<br />

<strong>Unit</strong> <strong>19</strong>: <strong>Postpartum</strong> <strong>and</strong> <strong>Postabortion</strong> <strong>Family</strong> <strong>Planning</strong> 425

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!